News

AbbVie fails in late-stage trial for Roche-partnered blood cancer therapy venetoclax
AbbVie (NYSE:ABBV) announced Monday a setback for a Phase 3 trial designed to test its Roche (OTCQX:RHHBF)-partnered leukemia ...